Eagle Asset Management Inc Care Dx, Inc. Transaction History

Eagle Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$16.06 - $26.39 $115,118 - $189,163	-7,168 Reduced 2.58%	270,622 $4.61 Million
Q2 2022 Aug 10, 2022	BUY	$20.49 - $39.72 $120,337 - $233,275	5,873 Added 2.16%	277,790 $5.97 Million
Q1 2022 May 12, 2022	BUY	$28.19 - $46.6 $415,830 - $687,396	14,751 Added 5.74%	271,917 $10.1 Million
Q4 2021 Feb 11, 2022	SELL	$41.2 - $73.6 $1.64 Million - $2.94 Million	-39,878 Reduced 13.42%	257,166 $11.6 Million
Q3 2021 Nov 10, 2021	SELL	$59.15 - $91.99 $2.86 Million - $4.44 Million	-48,298 Reduced 13.99%	297,044 $18.8 Million
Q2 2021 Aug 11, 2021	BUY	$63.02 - $95.11 $274,704 - $414,584	4,359 Added 1.28%	345,342 $31.6 Million
Q1 2021 May 14, 2021	BUY	$57.62 - $95.6 $19.6 Million - $32.6 Million	340,983 New	340,983 $24 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.